Showing 680 – 690 of 1157 results
-
Recro Pharma Inc Initiation
William Blair initiated research coverage of Recro Pharma, Inc. (REPH $1.90), a small-molecule finished-dose contract development and manufacturing organization (CDMO).
-
Ginkgo Bioworks Holdings Inc Initiation
William Blair initiated research coverage of Ginkgo Bioworks Holdings, Inc. (DNA $9.47). Based in Boston, Massachusetts, Ginkgo Bioworks has built the industry-standard horizontal platform for cell programming, which it uses to engineer cells on behalf of its customers.
-
Paya Holdings Inc Initiation
William Blair & Company initiated research coverage of Paya Holdings Inc. (PAYA $13.49), a provider of software-led, digital payments capabilities to over 100,000 merchants in the United States.
-
Doximity, Inc Initiation
William Blair initiated research coverage of Doximity, Inc. (DOCS $52.91). Doximity is the leading digital platform for U.S. medical professionals, supporting practitioners through a variety of clinical workflow tools that help improve provider productivity.
-
JOANN Inc Initiation
William Blair & Company initiated research coverage of JOANN Inc. (JOAN $10.99), the largest retailer of sewing products and accessories in the United States and a large and growing player in the arts and crafts category.
-
Karat Packaging Inc Initiation
William Blair initiated research coverage of Karat Packaging, Inc. (KRT $17.37), a fast-growing manufacturer and distributor of environmentally friendly, single-use disposable products, primarily used in restaurants and foodservice settings.
-
Amplitude Inc Initiation
William Blair initiated research coverage of Amplitude, Inc. (AMPL $66.69), a provider of digital optimization software.
-
Vivid Seats Inc Initiation
William Blair initiated research coverage of Vivid Seats Inc. (SEAT $13.25), an online ticket marketplace that operates in the United States.
-
Atea Pharmaceuticals Inc Initiation
William Blair & Company initiated research coverage of Atea Pharmaceuticals, Inc. (AVIR $33.17), a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics.
-
Instructure Inc Initiation
William Blair initiated research coverage of Instructure, Inc. (INST $19.66), a leading provider of SaaS solutions focused on the classroom in the education industry.